The WHO distinguishes “IDH-mutant“ GBM, harboring a mutation in the isocitrate-dehydrogenase-1-(IDH1)-gene, from “IDH-wild type” GBM (~95% of cases) [13, 17]. The gene discussed is IDH1; the disease is glioblastoma.